Transient Vascular Cell Integration and Intrinsic Media-Stimulated Endothelial Activation Reveal Diabetic Retinopathy Signatures in Human Retinal Organoids

The human eye relies on a delicate sheet of tissue at the back called the retina to turn light into the images we see. This tissue is not just a passive screen; it is a complex, living network of neurons that requires a constant supply of oxygen and nutrients delivered by a dense web of tiny blood vessels. Without this vascular support, the cells in the center of the retina begin to die, leading to blindness in conditions like diabetic retinopathy. For decades, scientists have tried to grow miniature versions of the human retina in the laboratory using stem cells. These tiny, self-organizing structures, known as organoids, have been invaluable for studying how the eye develops. However, a major limitation has persisted: these lab-grown retinas remain largely avascular, meaning they lack the blood vessels necessary to sustain them long-term. Consequently, they often fail to mature fully or to model diseases where blood vessel failure is the root cause.

Researchers have long sought to solve this by adding blood vessels to these lab-grown eyes, but doing so without destroying the intricate, layered structure of the retina has proven difficult. Simply mixing the two types of tissue often results in a disorganized mess where the delicate layers of neurons collapse. Furthermore, it has been unclear whether the blood vessels and immune cells needed to support the retina must be added from the outside, or if the retinal tissue itself holds the latent ability to generate these support cells under the right conditions. Understanding this distinction is critical for creating accurate models of eye disease, particularly for conditions like diabetes, where high blood sugar damages the tiny vessels in the eye, causing inflammation and vision loss.

A team of scientists at Newcastle University and collaborating institutions has now taken a significant step toward solving this puzzle. They successfully grew human retinal organoids that incorporated blood vessel cells and immune cells, but with a crucial twist: the integration was temporary, and the timing of the addition was key. By introducing these vascular cells at a specific early stage of development, the researchers found that the organoids could maintain their proper layered structure and even respond to light, much like a healthy human retina. Perhaps more surprisingly, they discovered that when they grew retinal organoids in a nutrient-rich, blood-vessel-promoting environment without adding any external vessels, the organoids spontaneously generated their own internal, inflammatory blood vessel-like cells. These self-made cells displayed genetic signatures strikingly similar to those seen in human eyes suffering from diabetic retinopathy, offering a new way to study the disease without needing to manipulate sugar levels in a dish.

The researchers began by creating "vascular organoids" from human stem cells. These are small, three-dimensional balls of tissue that naturally develop into a mix of blood vessel cells, supporting cells, and immune cells. They then tested two different strategies to merge these vascular organoids with developing retinal organoids. In the first approach, they tried fusing two fully formed organoids together, but this resulted in a loss of the retina's organized layers after a few weeks. The second approach proved far more successful. The team took the vascular organoids apart into individual cells and sprinkled them onto a flat sheet of developing retinal tissue before the tissue curled up into a 3D sphere. They did this at two different times: when the vascular cells were young (day 12) and when they were more mature (day 30).

The results showed that the timing of this introduction was everything. When the researchers added the younger, day-12 vascular cells, the organoids developed some structure, but the integration was less stable. However, when they added the more mature, day-30 vascular cells, the outcome was remarkable. The vascular cells migrated into the retinal tissue and persisted for a time, but crucially, they did so without disrupting the retina's delicate architecture. The organoids retained their distinct layers, with photoreceptors on the outside and nerve cells on the inside, just as they do in a human eye. Even more importantly, these organoids remained functional. When exposed to light, the nerve cells in the organoids fired electrical signals, indicating that the complex circuitry of the retina had formed correctly despite the presence of the new blood vessel cells.

While the vascular cells eventually faded away from the organoids after about 100 days, the experiment revealed a hidden capability within the retinal tissue itself. In a control group where the researchers grew retinal organoids in a special liquid designed to encourage blood vessel growth but did not add any external vascular cells, the organoids began to produce their own blood vessel-like cells. These cells were not the healthy, organized vessels found in a living eye. Instead, they appeared as disorganized clusters that expressed markers of inflammation and stress.

When the scientists analyzed the genetic code of these self-generated cells, they found a startling connection to human disease. The cells carried a specific set of genetic instructions that matched the profile of blood vessel cells from human eyes exposed to high levels of sugar, a hallmark of diabetes. These cells showed signs of inflammation and a transition toward a more rigid, scar-like state, which are early warning signs of diabetic retinopathy. This happened even though the researchers did not add extra sugar to the culture; the mere presence of the blood-vessel-promoting liquid was enough to trigger this disease-like state in the organoid's own cells.

The study also shed light on the immune system within the eye. The researchers found that immune cells, specifically a type of white blood cell known as microglia, appeared naturally in all the organoids, regardless of whether external cells were added. These cells moved through the tissue, changing their shape from round to branched as the organoids matured, mimicking the behavior of immune cells in a developing human eye. This suggests that the retina has an intrinsic ability to recruit and house its own immune defenses, a feature that is essential for studying how inflammation contributes to eye disease.

The findings challenge the assumption that all blood vessels and immune cells must be added from the outside to study retinal diseases. Instead, the research suggests that the retinal tissue itself contains the potential to generate these support systems, but that the environment in which they grow dictates whether they become healthy or diseased. When the environment is too aggressive or lacks the right physical cues, the organoids generate a chaotic, inflammatory version of blood vessels that mirrors the damage seen in diabetic retinopathy.

This work provides a new tool for understanding how blood vessel failure leads to blindness. By creating a model where the retina generates its own stressed blood vessels, scientists can now study the earliest molecular events of diabetic retinopathy in a human tissue context. The research also highlights the importance of timing and environment in tissue engineering. It shows that while adding mature vascular cells can support retinal development without causing damage, the conditions used to grow these tissues must be carefully controlled to avoid accidentally triggering disease states. The ability to grow a retinal organoid that is both vascularized and immunocompetent, while retaining its structural integrity, represents a significant advance in creating realistic models of the human eye for testing new treatments.